Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s472922 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Linghong Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Tranexamic Acid, Melanosis, Iontophoresis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
ORCID-Profile: Xu Liu, Xian Jiang
Zitieren
APA
Guo, L., Liu, X., Liu, Q., Xie, X., & Jiang, X. (2024). Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s472922
Vancouver
Guo L, Liu X, Liu Q, Xie X, Jiang X. Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s472922
BibTeX
@article{Guo2024,
author = {Guo, Linghong and Liu, Xu and Liu, Qingfeng and Xie, Xiaoqin and Jiang, Xian},
title = {Treatment of Melasma with Tranexamic Acid Essence Combined with Iontophoresis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s472922}
}
EUVIMED